These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 11134114

  • 1. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR, van Dulken H, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.
    Biermasz NR, van Dulken H, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2476-82. PubMed ID: 10902796
    [Abstract] [Full Text] [Related]

  • 3. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M.
    J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
    [Abstract] [Full Text] [Related]

  • 4. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
    Freda PU, Wardlaw SL, Post KD.
    J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
    [Abstract] [Full Text] [Related]

  • 5. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly.
    Biermasz NR, Smit JW, van Dulken H, Roelfsema F.
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):313-9. PubMed ID: 11940042
    [Abstract] [Full Text] [Related]

  • 6. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
    De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
    Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA.
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543
    [Abstract] [Full Text] [Related]

  • 9. Octreotide as primary therapy for acromegaly.
    Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL.
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [Abstract] [Full Text] [Related]

  • 10. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
    Kristof RA, Neuloh G, Redel L, Klingmüller D, Schramm J.
    J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU, Post KD, Powell JS, Wardlaw SL.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [Abstract] [Full Text] [Related]

  • 12. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
    Kreutzer J, Vance ML, Lopes MB, Laws ER.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [Abstract] [Full Text] [Related]

  • 16. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U, Quabbe HJ.
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [Abstract] [Full Text] [Related]

  • 17. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O, Beauregard C, Hardy J.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
    [Abstract] [Full Text] [Related]

  • 18. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
    Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
    [Abstract] [Full Text] [Related]

  • 19. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients.
    Shimon I, Cohen ZR, Ram Z, Hadani M.
    Neurosurgery; 2001 Jun; 48(6):1239-43; discussion 1244-5. PubMed ID: 11383725
    [Abstract] [Full Text] [Related]

  • 20. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
    Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
    Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.